Telesair, a medical gadget firm creating hospital-to-home merchandise for respiratory care, introduced it had raised $22 million in Collection A funding.

The spherical was led by Pasaca Capital with participation from Honeywell Ventures, ZhenCheng Capital, Shangbay Capital, Machine of Tomorrow Capital, Berkeley Catalyst Fund and Ultrastar Ventures LLC. 

The funding might be used to commercialize its Bonhawa Respiratory Humidifier, designed to be used within the ICU, and assist the event of a brand new product that goals to assist sufferers depart the hospital extra rapidly and keep at residence safely.

“Honeywell is aligned with Telesair’s mission to enhance lives via innovation in digital healthcare,” Patrick Hogan, managing director of Honeywell Ventures, stated in an announcement. “We’re impressed with their mission and know-how roadmap, and we’re excited to collaborate with them in vital areas reminiscent of superior sensing and distant affected person monitoring, enabled by synthetic intelligence and machine studying.”

ModifyHealth, which delivers medically tailor-made meals and affords digital assist from dietitians, raised $10 million in a Collection B funding spherical led by RC Capital with participation from present investor Nashville Capital Community.

The startup works with sufferers with continual situations like Sort 2 diabetes, hypertension, kidney illness, weight problems and irritable bowel syndrome. Modify, which raised its $2 million Series A in 2020, plans to make use of the funds to assist its development and increase its nationwide operations. 

“Food plan and way of life play an important function within the administration of continual well being situations and we’re simply scratching the floor on the influence we are able to make. RCC is a superb match for ModifyHealth and their strategic assist, healthcare experience, and shared imaginative and prescient will assist us ship outcomes extra quickly and broadly,” GB Pratt, founder and CEO of ModifyHealth, stated in an announcement.

Censinet, developer of healthcare cybersecurity software program, scored $9 million in a funding spherical led by MemorialCare Innovation Fund.

Different contributors within the elevate embrace Rex Well being Ventures, Ballad Ventures, LRVHealth, HLM Enterprise Companions, Schooner Capital, Excelerate Well being Ventures and Cedars Sinai. Censinet stated the spherical brings its complete funding pot to greater than $22 million. 

“With the variety of breaches escalating and ransomware now a direct menace to affected person security, the necessity for the healthcare trade to remodel cyber danger administration has by no means been extra pressing. Censinet’s distinctive danger change permits suppliers, payers and distributors to collaboratively handle third occasion and enterprise danger, repeatedly bettering danger posture in real-time and strengthening cybersecurity throughout all healthcare organizations,” Ed Gaudet, the corporate’s CEO and founder, stated in an announcement.

Dutch startup Lapsi Well being raised $3.7 million in a seed funding spherical led by Sahir Ali of Modi Ventures.

The corporate is developing digital biomarkers utilizing auscultatory sound, or inside physique sounds from the guts, lungs and stomach. Lapsi will use the capital to proceed to develop their instruments, undergo the FDA and increase into the U.S. market. 

CARI Well being, which is creating a wearable sensor for treatment administration, raised $2.3 million in seed funding. 

The spherical was led by the San Diego Angel Convention (SDAC) with participation from NuFund Enterprise Group, Cove Fund, Chemical Angel Fund, Medical Gadgets of Tomorrow and angel buyers. 

The startup is making a sensor worn on the pores and skin that permits for distant treatment monitoring. If treatment ranges fall outdoors of set tips, sufferers, members of the family and suppliers can obtain alerts.

The capital will go towards finishing its first human scientific research, increasing its mental property portfolio and planning for a regulatory submission with the FDA. CARI will first give attention to monitoring drugs for opioid use dysfunction (MOUD).

“We’re passionate concerning the potential to make an influence and construct one thing larger than ourselves,” founder and CEO Patrik Schmidle stated in an announcement. “Wearable distant monitoring can be life-changing for tons of of hundreds of MOUD sufferers, who below right this moment’s commonplace of care have to point out up virtually every day for clinic visits, particularly to start with of therapy.”